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Abstract 
 
Objective:  The objective of this selective EBM review is to determine whether or not 
therapeutic hypothermia is an effective treatment in improving survival rates in pediatric patients 
that have suspected brain injuries.  
 
Study Design: Two randomized control trials and one cohort analysis published in 2015 to 2016 
were selected based on their relevance to the clinical question. 
 
Data Sources: Studies were obtained by searching PubMed, OVID, Medline databases. All 
articles were published in English and peer viewed journals.   
 
Outcome Measured: The outcome measured was survival rates at 12-month post injury compared 
between the groups that received therapeutic hypothermia or normotherapy in pediatric patients.  
 
Results: All three studies reviewed did not find a statistically significant improvement in survival 
rates at 12 months with the use of therapeutic hypothermia in pediatric patients with brain 
injuries. There was a variation between studies on therapeutic hypothermia technique and 
duration utilized, injury to treatment times, as well as type of brain injury sustained.  
 
Conclusions: The results of the systematic review of the three studies showed that therapeutic 
hypothermia does not improve survival rates at the 12-month mark following an acute brain 
injury in pediatric patients at this time. However, it should be stated that further investigation in 
the subject matter should include similar hypothermia therapy techniques, faster injury to 
treatment times, and larger sample sizes.  
 
 Keywords: Therapeutic hypothermia, randomized, pediatric, traumatic brain injury, drowning, 
pediatric cardiac arrest.
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Introduction 
 It’s cool to be cold, or at least that is the thinking with therapeutic hypothermia. Targeted 
temperature management (TTM) or hypothermia therapy is the intentional lowering of the core 
body temperature from its normal temperature of 37°C to a range of 32° to 34°C in an effort to 
improve brain injury outcomes1. Hypothermia has been used to manage problems that arise from 
global ischemia and reperfusion injuries2. Brain injuries can be considered such events and are 
defined as non-degenerative non-congenital insults to brain tissue that can possibly cause 
permanent or temporary impairment of cognitive, physical, psychosocial functions with an 
associated diminished or altered state of consciousness1.  
 Brain injuries can be divided into two categories, primary and secondary. Primary brain 
injuries include direct impacts with the brain such as a concussion, contusion, coup-contrecoup, 
and diffuse axonal injury. Primary injuries also involve insults to brain tissue such as hypoxia or 
anoxic injuries either due to an illness, disease process, or cardiac arrest. Secondary brain 
injuries refer to the changes that occur within hours to days after a primary brain injury. These 
changes include endogenous cascade of cellular and biochemical events that trigger excessive 
amounts of the excitatory amino acid glutamate3. This excessive amount triggers neuronal cell 
death and is termed “excitotoxicity”3. The destructive cascade appears to be not only dependent 
on severity, but also age-dependent in which immature cells are more susceptible making 
pediatric patients more at risk3. 
 The severity of a brain injury is also clinically calculated during a neurological 
assessment called the Glasgow Coma Scale (GCS) where a patient’s motor, verbal, and eye 
response are all rated and scored. A score is ranged between 3 and 15, with 15 being normal. A 
score of 13-16 is considered a mild injury, 9 to 12 moderate, and 3 to 8 being severe3. 
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 Brain injuries are the most common cause of morbidity and mortality in children and 
encompass 90% of all pediatric injury related deaths4. In a 2013 study by Robertson et al, it was 
discovered that across 24 pediatric intensive care units the average bill in treating brain injuries 
was $46,784 for an average 5.3 day stay4. Hospital stays ranged from 1 to 5,324 days and the 
most expensive bill costing $7.8 million4.  
 The issue with managing brain injuries in pediatrics is appropriately treating the 
secondary injury. Currently, there is no standard of therapy for this secondary process or halting 
the excitatory process associated with neuronal cell death3. However, hypothermia has been 
shown in experimental trials to be neuroprotective against secondary brain injury by decreasing 
cerebral metabolism, inflammation, and excitotoxicity3. The only absolute contraindication to 
hypothermic therapy is situations in which aggressive treatment is not warranted2. It has been 
suggested that therapeutic hypothermia be utilized in pediatric brain injuries to protect 
developing brains and decrease the economic burden associated with these injuries.  
Objective 
 The objective of this selective EBM review is to determine whether or not “therapeutic 
hypothermia is an effective treatment in improving survival rates in pediatric patients that have 
suspected brain injuries.”   
Search Strategy Methods 
 This investigation looked at two randomized controlled trials (RCT) and one cohort 
study. Selection for the studies used were based on several factors. The population was any 
pediatric patient, ages 48 hours old to 18 years old that had suspected brain injuries. The brain 
injuries included both hypoxic events and physical head trauma. Within the studies reviewed this 
was demonstrated as children who required chest compressions for at least 2 minutes and were 
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mechanically ventilated, had a GCS less than 9, or an abnormal CT scan. The interventions in all 
three studies included the use of therapeutic hypothermia. Typically, this included an array of 
techniques that centered on cooling a patient’s body temperature to between 32°and 34°C for a 
period of time. This group was compared to patients who underwent normothermic treatment. 
These patients kept a strict body core temperatures of 36°to 37° C and were strictly monitored. 
The outcomes addressed in reviewing the studies included individual 12-month post injury 
survival status. 
 Studies were obtained by searching PubMed, OVID, Medline Database during 2016. Key 
words used were “therapeutic hypothermia”, “randomized”, “pediatrics”, “traumatic brain 
injury”, “drowning”, and “pediatric cardiac arrest”. All articles were published in English and 
were peer reviewed. The author conducted all the appropriate research on the subject and 
ultimately articles were selected based on relevance to clinical questions with patient oriented 
outcomes. Inclusion criteria for articles included pediatric patients ages 18 years old or younger 
and therapeutic use of hypothermia for a brain injury. Exclusion criteria were absent survival 
rates at the 12-month mark, older population, and absence of suspected brain injury. The 
inclusion and exclusion criteria for each article is listed below (see Table 1). Statistical analysis 
for this review included calculations concerning the control event rate (CER), experimental event 
rate (EER), relative risk reduction (RRR), absolute risk reduction (ARR), and numbers needed to 
treat (NNT).  All which were calculated by the author using dichotomous data found in each 
study.  
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Table 1: Demographics & Characteristics of Included Studies 
Study Type Number 
of 
Patients 
Age  Inclusion 
Criteria 
Exclusion 
Criteria 
Withdrawn Interventions  
Beca5 RCT 55 1 to 15 
y.o.  
Children 
who could be 
randomized, 
mechanically 
ventilated, 
GCS less 
than 9, and 
who had a 
abnormal CT 
scan  
Children who 
could not be 
randomized within 
6 hours, who had 
penetrating brain 
injury, who had 
fixed dilated 
pupils with GCS 
of 3, had a 
cervical spinal 
cord injury, had a 
disability prior to 
injury, acute 
epidural 
hematoma, 
refractory shock, 
or suspected non-
accidental trauma 
(NAT).  
5 Induced 
therapeutic 
hypothermia 32-
33∘C for 72 
hours, rewarmed 
after 72 hours. 
Rate of 
rewarming 0.5∘C 
every 3 hours 
Moler6 RCT 295 48 
hours 
old to 
18 y.o.  
Children 
with cardiac 
arrest that 
required 
chest  
compressions 
for at least 2 
minutes and 
remained on 
dependent on 
mechanical 
ventilation 
Inability to 
randomize within 
6 hours, GCS 
score of 5 or 6, 
decision by 
clinical team to 
with withhold 
aggressive 
treatment, or 
sustained major 
trauma 
8 Hypothermia 32.0 
- 34.0∘C for 48 
hour, rewarmed 
over 16 hours or 
longer to 36.8∘C 
for a total of  120 
hours TTM 
Moler7 Cohort 74 48 
hours 
old to 
18 y.o.  
Children 
who 
sustained 
chest 
compressions 
for at least 2 
minutes and 
remained 
comatose on 
a mechanical 
ventilation, 
and was a 
victim of 
drowning. 
Inability to 
randomize within 
6 hours, GCS 
score of 5 or 6,  
motor response 
subscale 1 to 6 
score, lack of 
commitment or 
aggressive care, 
associated major 
trauma, or 
drowning in ice 
covered water 
5 Hypothermia 32.0 
- 34.0∘C for 48 
hour, rewarmed 
over 16 hours or 
longer to 36.8∘C 
for a total of  120 
hours TTM 
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Outcomes Measured  
 The outcome measured in this review was survival at the 12-month post injury mark. 
Mortality was compared between the groups that received therapeutic hypothermia to 
normothermic therapy in pediatric patients with brain injuries. 
Results  
 All three studies gave insight on survival rates of pediatric patients with brain injuries 
with the use of therapeutic hypothermia versus normothermia.  The articles reviewed provided 
dichotomous data that could be used for calculations of RRR, ARR, and NNT at the desired time 
frame of 12 months status post injury per individual patient.  
 In the Beca et al study 92 patients were eligible and 55 were recruited for randomization 
from 8 pediatric intensive care units (PICU) in Australia, New Zealand, and Canada5. This study 
utilized temperature control through a cooling blanket and IV fluid bolus and monitored via a 
temperature probe in the esophagus. Hypothermia was maintained for a minimum of 72 hours 
and rewarming was induced at a rate of 0.5°c every three hours5. During the course of treatment 
5 had management protocol violations and were removed from the study’s results5.  Of the 
remaining 50 patients, 24 patients were randomized to therapeutic hypothermia and 26 patients 
to normothermia5. The trial reported that at 12 months 4% of the normothermia group and 13% 
of the hypothermia group had died. The results were not significantly different (p = 0.34)5. 
Extracted information for use of therapeutic hypothermia demonstrated a RRR of 2.25% and an 
ARR of 9%. The numbers needed to treat was 12, meaning that 12 patients needed to be treated 
with therapeutic hypothermia in order to see a benefit in survival compared to control (Table 2). 
Additionally, this study found no difference in complication rates between the two groups of 
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treatment over the course of 12 months, but did cite that rewarming is a difficult process with 
hypotension as a common issue5.  
 In the Moler et al study in 2015, 295 patients enrolled in the randomized controlled study 
at 38 children’s hospitals across United States and Canada6.  The therapeutic hypothermia group 
was managed for a total of 120 hours and achieved 48 hours of temperatures at 33ºC using 
Blanketrol III cooling units applied anteriorly and posteriorly6. Patients were rewarmed over 16 
hours or longer to 36.8°C6. Temperature was monitored via esophageal, rectal, or bladder device.  
3 patients achieved temperature management through extracorporeal membrane oxygenation 
(ECMO). The normothermia group was aggressively monitored for 120 hours at 36.8°C6. At 12 
months post incident mortality was assessed amongst 287 patients. Survival was reported as 38% 
of the therapeutic hypothermia patients and 29% of the normothermia with a relative likelihood 
of 1.29, a 95% confidence interval (CI) 0.93 to 1.79, (P = 0.13)6.  Therefore, there was no 
significant difference between groups. Additionally, obtained information from the study 
provided a RRR of -12.7% and an ARR of -9.0%. The numbers needed to treat was -11 (Table 
2). A negative number means that for every 11 patients who were treated with therapeutic 
hypothermia there was one fewer incidence of survival in the normothermia group. The study 
reports that mortality at 28 days status post incident did not significantly differ between the 
groups, 57% hypothermia vs 67% normothermia (P=0.08)6. The primary cause of death for both 
groups of these patients were brain death or withdrawal of life sustaining therapy due to poor 
neurological prognosis6. The incidence of complications such as bleeding, infection, and 
arrhythmias were similar among both groups6. However, hypokalemia and thrombocytopenia 
occurred more frequently in the hypothermia group, and renal replacement therapy more 
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common in the normothermia group6. Overall, this study fails to prove that therapeutic 
hypothermia is beneficial in improving survival rates.   
 The Moler et al cohort study of 2016 was conducted selectively on pediatric drownings. 
At 24 PICUs 74 patients were reviewed7. This study used 48 hours of temperatures at 33ºC using 
Blanketrol III cooling units applied anteriorly and posteriorly7. Patients were rewarmed over 16 
hours or longer to 36.8°C7. Temperature was monitored via esophageal, rectal, or bladder device. 
No ECMO was used.  At the individual 12-month status post incident mark, 5 patients’ status 
was unknown. Of the remaining 69 patients, 49% of the hypothermia group and 42% of the 
normothermia group were alive at 12 months with a 95% CI, 0.68-1.99 (p=0.58) that 
demonstrate the results were not statistically significant7. Extracted data gave a RRR of -11%, an 
ARR of -6.5%, and a -15 NNT (Table 2). The negative number to treat indicates that for every 
15 patients treated with hypothermia there was one fewer incident in the normothermia group. 
Conversely, this study is limited by the relative small sample size. As with the other studies it 
coincides to the belief that therapeutic hypothermia does not appear to improve survival rates at 
12 months.  
Table 2: Comparison of outcomes measured of included studies 
Study Number of Patients CI 
P-
value 
RRR 
(%) 
ARR 
(%) 
NNT 
Beca5 50 N/A 0.34* 2.25% 8.70% 12 
Moler6 287 0.93 - 1.79 0.13 -12.70% -9.00% -11 
Moler7 69 0.68 - 1.99 0.58 -11.00% -6.50% -15 
*Data based off deaths rather than survival  
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Discussion 
 The goal of this systematic review was to determine if therapeutic hypothermia improved 
survival rates. Therefore, it should be noted that the above studies have their own limitations to 
proving a true benefit of therapeutic hypothermia. Sample size is a crucial factor for creating 
statistically significant data. Both Beca et al and Moler et al 2016 contained small sample sizes 
respectfully. Each had under 70 total participants that were available for review at the end of 12 
months5,7. Among studies reviewed there was also insight that a variation of conducting 
therapeutic hypothermia may have occurred and different hospitals might have used different 
protocols. The time of total TTM varied, methods of conducting the reduced body temperature, 
method of monitoring, and rewarming process differ just among the three studies reviewed.  
 Another limitation to the studies in review was time to treatment. The goal of medical 
therapy is to reduce the secondary injuries associated with a brain injury. In reviews of the Beca 
et al study the median time from injury to target temperature for hypothermia patients was 9.3 
hours5. The average timeframe for Moler et al 2016 cohort study was 5.8 hours from return of 
circulation to treatment initiation7. The suspected area of delay to treatment is obtaining consent 
during a very critical and emotional timeframe.  Medical treatment requires providers to obtain 
consent before initiating treatment.  The Beca et al study mentions foregoing consent by 
mentioning that emergency care research meets criteria to override or defer consent when there is 
a delay. The study included this type of thinking with 8 patients at 4 of the research sites, as 
patients were randomized without consent5. The deferred consent proved no problems later for 
both researchers and ethic committees. Initiating therapy sooner could have a positive effect and 
slow the secondary brain injury destructive process. In turn this could improve survival of these 
pediatric patients and should be sought after in future studies.     
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Conclusions  
 The articles included in this systematic review justify the conclusion that therapeutic 
hypothermia in pediatric brain injuries does not improve survival rates. However, since the 
research supports use in the adult population further investigation can be justified.  Additional 
studies are warranted, especially with a reduction in injury to treatment times. Standardized 
hypothermic techniques in a larger sample could show similar results in pediatric use when 
compared to adults. The current use of therapeutic hypothermia in children doesn’t work as 
hoped, but it would be a lot cooler if it did in the future. 
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